What the superinvestors bought and sold in 2025 Q4
2025 Q4
137 of 137 filedThe quarter at a glance
87 of 136 managers were net sellers. Setting price aside, they took $12.7B out, led by Information Technology (−$6.1B), while adding to Energy (+$4.9B). BN was the most widely bought stock (12 bought, 0 sold); GOOGL / GOOG the most widely sold (36 sold, 17 bought).
Net buyers
46 of 136 managers
87 sold more than they bought · 3 about even
Net bought
−$12.7B
Price moves taken out; prices alone moved the book +$37.7B.
Positions opened
766
747 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter
+2.1%
SPY +2.4%,
0.2 pts behind.
Price only.
Most bought and sold
Ranked by how many managers bought minus how many sold, with price moves taken out. Open a stock to see who.
Most bought
-
1 BN Brookfield Corp. 12 bought · 0 sold +$3B
Bought by
- Josh Tarasoff - Greenlea Lane Capital Management added 19.0% → 18.9%
- Chuck Akre - Akre Capital Management added 13.1% → 13.5%
- Steven Check - Check Capital Management added 6.6% → 5.9%
- Stephen Mandel - Lone Pine Capital added 5.1% → 5.4%
- Thomas Gayner - Markel Group added 4.9% → 4.8%
- Third Avenue Management added 4.8% → 4.6%
- Dan Loeb - Third Point added 3.6% → 3.9%
- Arnold Van Den Berg - Van Den Berg Management I added 3.5% → 3.1%
and 4 more
Sold by
No manager sold.
-
2 DASH Doordash Inc. 11 bought · 0 sold +$1.6B
Bought by
- Henry Ellenbogen - Durable Capital Partners added 3.4% → 7.7%
- Ram Parameswaran - Octahedron Capital Management opened 5.3% of book
- Stephen Mandel - Lone Pine Capital opened 4.2% of book
- Philippe Laffont - Coatue Management added 1.6% → 2.5%
- Lee Ainslie - Maverick Capital added 0.02% → 0.87%
- Cathie Wood - Ark Investment Management added 0.34% → 0.46%
- George Soros - Soros Fund Management added 0.41% → 0.37%
- Davidson Kempner Capital Management opened 0.36% of book
and 3 more
Sold by
No manager sold.
-
3 NVDA Nvidia Corporation 19 bought · 10 sold +$1.6B
Bought by
- Brad Gerstner - Altimeter Capital Management added 18.8% → 22.7%
- Grant Wonders - Voyager Global Management added 11.7% → 21.0%
- Ram Parameswaran - Octahedron Capital Management added 7.0% → 11.8%
- Nehal Chopra - Ratan Capital Management added 9.3% → 10.8%
- Marc Stad - Dragoneer Investment Group added 8.6% → 10.8%
- Glen Kacher - Light Street Capital Management added 8.7% → 9.8%
- Duan Yongping - H&H International Investment added 0.76% → 7.7%
- Dan Loeb - Third Point added 5.9% → 7.6%
and 11 more
Sold by
- Mairs & Power cut 9.8% → 8.9%
- Alex Sacerdote - Whale Rock Capital Management cut 7.0% → 2.9%
- Chase Coleman - Tiger Global Management cut 6.8% → 6.9%
- David Tepper - Appaloosa cut 4.8% → 4.6%
- Philippe Laffont - Coatue Management cut 4.5% → 4.3%
- Polen Capital Management cut 3.8% → 4.2%
- Kentucky Trust Co. - Kentucky Trust cut 1.8% → 1.6%
- Davidson Kempner Capital Management cut 1.6% → 0.85%
and 2 more
-
4 RKT Rocket Cos Inc. 9 bought · 0 sold +$1.1B
Bought by
- Leon Cooperman - Omega Advisors opened 13.5% of book
- Valueact Capital - Valueact Holdings added 8.3% → 10.9%
- Henry Ellenbogen - Durable Capital Partners added 1.6% → 3.2%
- Dan Loeb - Third Point added 0.86% → 2.5%
- Gavin Baker - Atreides Management added 0.38% → 0.85%
- Philippe Laffont - Coatue Management opened 0.33% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.07% of book
- George Soros - Soros Fund Management opened <0.01% of book
and 1 more
Sold by
No manager sold.
-
5 GEHC Ge Healthcare Technologies, Inc. 7 bought · 0 sold +$920M
Bought by
- Ben Jacobs - Anomaly Capital Management opened 5.2% of book
- Leon Cooperman - Omega Advisors added 1.4% → 1.8%
- Bill Nygren / Oakmark - Harris Associates L P added 1.3% → 1.6%
- Dodge & Cox added 1.1% → 1.4%
- Dan Sundheim - D1 Capital Partners added 0.86% → 1.4%
- George Soros - Soros Fund Management opened 0.04% of book
- First Eagle Investment Management opened <0.01% of book
Sold by
No manager sold.
-
6 SPY Spdr S&P 500 ETF Tr 9 bought · 2 sold +$226M
Bought by
- Hillman Capital Management opened 2.9% of book
- Lewis Sanders - Sanders Capital added 1.4% → 1.6%
- George Soros - Soros Fund Management added 0.93% → 1.1%
- Don Yacktman - Yacktman Asset Management added 0.04% → 0.31%
- Vulcan Value Partners added <0.01% → 0.08%
- Samantha Mclemore - Patient Capital Management added 0.01% → 0.03%
- Polen Capital Management added <0.01% → 0.02%
- Bill Nygren / Oakmark - Harris Associates L P added <0.01% → <0.01%
and 1 more
Sold by
- Senator Investment Group cut 2.8% → 0.08%
- Davidson Kempner Capital Management cut 0.03% → 0.02%
-
7 TXN Texas Instrs Inc. 7 bought · 0 sold +$192M
Bought by
- Torray Investment Partners added 2.8% → 3.5%
- Christopher Davis - Davis Selected Advisers added 2.2% → 2.2%
- David Katz - Matrix Asset Advisors added 1.7% → 2.1%
- Robert Olstein - Olstein Capital Management added 0.83% → 0.96%
- Dan Sundheim - D1 Capital Partners opened 0.79% of book
- Arnold Van Den Berg - Van Den Berg Management I opened 0.20% of book
- George Soros - Soros Fund Management opened 0.20% of book
Sold by
No manager sold.
-
8 NFLX Netflix Inc. 11 bought · 4 sold −$1.1B
Bought by
- Rule One Partners added 6.5% → 5.3%
- Thomas Russo - Gardner Russo & Quinn added 6.6% → 5.1%
- Glen Kacher - Light Street Capital Management opened 2.9% of book
- Philippe Laffont - Coatue Management added 1.8% → 2.5%
- Chase Coleman - Tiger Global Management added 0.75% → 0.77%
- Cathie Wood - Ark Investment Management opened 0.10% of book
- Lee Ainslie - Maverick Capital opened 0.05% of book
- First Pacific Advisors added 0.03% → 0.02%
and 3 more
Sold by
- Mala Gaonkar - Surgocap Partners closed was 6.2%
- Alex Sacerdote - Whale Rock Capital Management closed was 3.3%
- Polen Capital Management cut 1.9% → 0.07%
- Andreas Halvorsen - Viking Global Investors closed was 1.6%
-
9 SPOT Spotify Technology S A 6 bought · 0 sold +$765M
Bought by
- Philippe Laffont - Coatue Management added 3.1% → 3.6%
- Dan Sundheim - D1 Capital Partners opened 2.1% of book
- Ben Jacobs - Anomaly Capital Management opened 1.8% of book
- Dan Loeb - Third Point opened 0.80% of book
- Polen Capital Management added 0.03% → 0.18%
- Stephen Mandel - Lone Pine Capital opened 0.08% of book
Sold by
No manager sold.
-
10 ISRG Intuitive Surgical Inc. 6 bought · 0 sold +$726M
Bought by
- Mala Gaonkar - Surgocap Partners opened 4.1% of book
- Polen Capital Management opened 2.0% of book
- Philippe Laffont - Coatue Management added 0.78% → 1.1%
- Mairs & Power opened 0.34% of book
- Cathie Wood - Ark Investment Management added 0.08% → 0.18%
- Francois Rochon - Giverny Capital opened <0.01% of book
Sold by
No manager sold.
Not counted as buying: 179 IPOs, spin-offs and new listings.
Most sold
-
1 GOOGL / GOOG Alphabet 17 bought · 36 sold −$3.1B
Sold by
- Andrew Steginsky - Steginsky Capital cut 31.0% → 36.2%
- Triple Frond Partners cut 14.6% → 11.5%
- Ruane, Cunniff & Goldfarb cut 14.6% → 16.2%
- Lindsell Train cut 13.3% → 16.6%
- First Pacific Advisors cut 13.1% → 13.5%
- Grant Wonders - Voyager Global Management cut 12.5% → 8.5%
- Thomas Russo - Gardner Russo & Quinn cut 12.2% → 13.4%
- Lewis Sanders - Sanders Capital cut 10.1% → 11.5%
and 28 more
Bought by
- Mala Gaonkar - Surgocap Partners added 6.0% → 10.9%
- Alex Sacerdote - Whale Rock Capital Management added 3.4% → 8.4%
- David Tepper - Appaloosa added 4.6% → 8.1%
- Glen Kacher - Light Street Capital Management added 5.0% → 6.5%
- Christopher Davis - Davis Selected Advisers added 4.3% → 5.4%
- Ben Jacobs - Anomaly Capital Management added 1.3% → 4.0%
- Lee Ainslie - Maverick Capital added 0.05% → 3.8%
- John Armitage - Egerton Capital (UK) opened 3.7% of book
and 9 more
-
2 BAC Bank America Corp. 0 bought · 13 sold −$4.9B
Sold by
- Guy Spier - Aquamarine Zurich AG closed was 12.5%
- Warren Buffett - Berkshire Hathaway cut 11.0% → 10.4%
- Dan Sundheim - D1 Capital Partners cut 3.3% → 0.64%
- Harry Burn - Sound Shore Management cut 3.2% → 2.8%
- Lee Ainslie - Maverick Capital closed was 2.3%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.2% → 1.4%
- Andreas Halvorsen - Viking Global Investors cut 1.5% → 0.66%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.3%
and 5 more
Bought by
No manager bought.
-
3 INTU Intuit 3 bought · 14 sold −$2.1B
Sold by
- Dennis Hong - Shawspring Partners cut 11.6% → 6.3%
- Ako Capital cut 6.5% → 2.4%
- Ben Jacobs - Anomaly Capital Management cut 5.0% → 2.0%
- Jensen Investment Management cut 4.6% → 2.8%
- Dev Kantesaria - Valley Forge Capital Management cut 4.3% → 3.3%
- Henry Ellenbogen - Durable Capital Partners closed was 2.2%
- Gavin Baker - Atreides Management closed was 1.8%
- Polen Capital Management cut 1.5% → 1.4%
and 6 more
Bought by
- Torray Investment Partners opened 2.1% of book
- Cathie Wood - Ark Investment Management added 0.19% → 0.31%
- Lee Ainslie - Maverick Capital added <0.01% → 0.05%
-
4 META Meta Platforms Inc. 13 bought · 23 sold −$1.5B
Sold by
- Robert Vinall - Rv Capital AG cut 18.8% → 20.9%
- Pat Dorsey - Dorsey Asset Management cut 12.7% → 9.2%
- Triple Frond Partners cut 8.1% → 6.7%
- Philippe Laffont - Coatue Management cut 7.3% → 6.2%
- Stephen Mandel - Lone Pine Capital closed was 7.1%
- Alex Sacerdote - Whale Rock Capital Management cut 6.3% → 4.0%
- Terry Smith - Fundsmith cut 5.8% → 5.3%
- Grant Wonders - Voyager Global Management closed was 5.4%
and 15 more
Bought by
- Valueact Capital - Valueact Holdings added 9.5% → 9.8%
- Nehal Chopra - Ratan Capital Management added 8.5% → 7.9%
- Lewis Sanders - Sanders Capital added 8.6% → 7.6%
- Eric Mandelblatt - Soroban Capital Partners added 4.0% → 6.0%
- David Tepper - Appaloosa added 3.7% → 5.7%
- Dan Sundheim - D1 Capital Partners added 2.3% → 2.3%
- Mairs & Power added 1.8% → 2.0%
- David Katz - Matrix Asset Advisors added 1.9% → 1.9%
and 5 more
-
5 C Citigroup Inc. 0 bought · 9 sold −$935M
Sold by
- First Pacific Advisors cut 5.3% → 5.4%
- Richard Pzena - Pzena Investment Management cut 4.1% → 3.7%
- Harry Burn - Sound Shore Management cut 3.3% → 2.9%
- Francis Chou - Chou Associates Management cut 2.8% → 1.9%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.2% → 1.5%
- Sarah Ketterer - Causeway Capital Management cut 1.3% → 1.1%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.3%
- Greenhaven Associates cut 0.13% → 0.06%
and 1 more
Bought by
No manager bought.
-
6 AAPL Apple Inc. 2 bought · 10 sold −$3.6B
Sold by
- Duan Yongping - H&H International Investment cut 60.4% → 50.3%
- Warren Buffett - Berkshire Hathaway cut 22.7% → 22.6%
- David Rolfe - Wedgewood Partners cut 7.8% → 7.3%
- Jensen Investment Management cut 7.3% → 8.5%
- Torray Investment Partners cut 1.8% → 1.9%
- Robert Olstein - Olstein Capital Management cut 0.77% → 0.72%
- Glen Kacher - Light Street Capital Management cut 0.46% → 0.42%
- Lee Ainslie - Maverick Capital closed was 0.04%
and 2 more
Bought by
- George Soros - Soros Fund Management added 1.3% → 1.3%
- Ron Baron - Bamco Inc. (Baron Capital) added <0.01% → 0.01%
-
7 AXP American Express Co. 0 bought · 8 sold −$132M
Sold by
- Guy Spier - Aquamarine Zurich AG cut 22.0% → 16.3%
- Torray Investment Partners cut 2.6% → 1.3%
- Mairs & Power cut 0.53% → 0.57%
- Christopher Bloomstran - Semper Augustus Investments Group cut 0.17% → 0.15%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.13% → 0.10%
- Kahn Brothers Group cut 0.07% → 0.04%
- Dodge & Cox cut 0.06% → 0.06%
- Thomas Russo - Gardner Russo & Quinn cut 0.05% → 0.05%
Bought by
No manager bought.
-
8 APP Applovin Corp. 2 bought · 9 sold −$1.3B
Sold by
- Ben Tsai - Spruce House Investment Management cut 38.2% → 35.2%
- Alex Sacerdote - Whale Rock Capital Management cut 8.2% → 7.0%
- Dan Sundheim - D1 Capital Partners cut 6.9% → 4.2%
- Stephen Mandel - Lone Pine Capital cut 5.8% → 3.9%
- Chase Coleman - Tiger Global Management cut 4.4% → 2.9%
- Henry Ellenbogen - Durable Capital Partners cut 1.0% → 1.0%
- Davidson Kempner Capital Management closed was 0.60%
- Andreas Halvorsen - Viking Global Investors closed was 0.30%
and 1 more
Bought by
- Nehal Chopra - Ratan Capital Management added 2.3% → 7.8%
- Christopher Davis - Davis Selected Advisers added 0.84% → 0.75%
-
9 BABA Alibaba Group Holding, Ltd. 5 bought · 12 sold −$1.2B
Sold by
- David Tepper - Appaloosa cut 15.6% → 10.9%
- Samantha Mclemore - Patient Capital Management cut 3.5% → 0.57%
- Duan Yongping - H&H International Investment cut 3.4% → 2.1%
- Glen Kacher - Light Street Capital Management closed was 3.2%
- Guy Spier - Aquamarine Zurich AG closed was 2.7%
- Brad Gerstner - Altimeter Capital Management closed was 2.3%
- Ben Jacobs - Anomaly Capital Management closed was 1.7%
- Dodge & Cox cut 1.1% → 0.79%
and 4 more
Bought by
- Dennis Hong - Shawspring Partners opened 10.4% of book
- Dan Loeb - Third Point opened 1.7% of book
- Cathie Wood - Ark Investment Management added 0.22% → 0.62%
- Ron Baron - Bamco Inc. (Baron Capital) added 0.48% → 0.43%
- Bill Nygren / Oakmark - Harris Associates L P added <0.01% → <0.01%
-
10 SCHW The Charles Schwab Corp. 1 bought · 8 sold −$970M
Sold by
- Claude Leveille - Courant Investment Management cut 15.0% → 16.6%
- Ruane, Cunniff & Goldfarb cut 10.0% → 8.7%
- Don Yacktman - Yacktman Asset Management cut 5.5% → 5.5%
- Dodge & Cox cut 4.3% → 4.1%
- Dan Sundheim - D1 Capital Partners cut 4.2% → 2.9%
- Andreas Halvorsen - Viking Global Investors cut 4.1% → 3.7%
- Mairs & Power cut 0.27% → 0.26%
- Greenhaven Associates cut 0.02% → 0.02%
Bought by
- Lee Ainslie - Maverick Capital added 1.1% → 1.3%
Not counted as selling: 178 mergers and delistings.
Opened and closed
New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.
Opened by the most managers
-
AMZN Amazon.com, Inc. 8 managers avg 4.0% of book · Seth Klarman - Baupost Group, Estuary Capital Management and 6 more
Opened by
- Seth Klarman - Baupost Group opened 9.3% of book
- Estuary Capital Management opened 6.5% of book
- Dennis Hong - Shawspring Partners opened 5.1% of book
- Jensen Investment Management opened 4.1% of book
- Dan Sundheim - D1 Capital Partners opened 2.9% of book
- David Rolfe - Wedgewood Partners opened 2.5% of book
- Andreas Halvorsen - Viking Global Investors opened 1.9% of book
- Thomas Russo - Gardner Russo & Quinn opened <0.01% of book
-
DASH Doordash Inc. 6 managers avg 1.7% of book · Ram Parameswaran - Octahedron Capital Management, Stephen Mandel - Lone Pine Capital and 4 more
Opened by
- Ram Parameswaran - Octahedron Capital Management opened 5.3% of book
- Stephen Mandel - Lone Pine Capital opened 4.2% of book
- Davidson Kempner Capital Management opened 0.36% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.18% of book
- Kentucky Trust Co. - Kentucky Trust opened 0.02% of book
- First Eagle Investment Management opened <0.01% of book
-
AVGO Broadcom Inc. 6 managers avg 1.6% of book · Estuary Capital Management, Farallon Capital Management and 4 more
Opened by
- Estuary Capital Management opened 6.4% of book
- Farallon Capital Management opened 1.5% of book
- Jensen Investment Management opened 0.97% of book
- Davidson Kempner Capital Management opened 0.41% of book
- George Soros - Soros Fund Management opened 0.41% of book
- Sarah Ketterer - Causeway Capital Management opened <0.01% of book
-
GOOGL / GOOG Alphabet 6 managers avg 1.3% of book · John Armitage - Egerton Capital (UK), Andreas Halvorsen - Viking Global Investors and 4 more
Opened by
- John Armitage - Egerton Capital (UK) opened 3.7% of book
- Andreas Halvorsen - Viking Global Investors opened 2.2% of book
- Nehal Chopra - Ratan Capital Management opened 1.7% of book
- Richard Pzena - Pzena Investment Management opened 0.16% of book
- Senator Investment Group opened 0.14% of book
- Christopher Bloomstran - Semper Augustus Investments Group opened 0.03% of book
-
LYV Live Nation Entertainment In 5 managers avg 5.2% of book · Pat Dorsey - Dorsey Asset Management, Spencer Waxman - Shannon River Fund Management and 3 more
Opened by
- Pat Dorsey - Dorsey Asset Management opened 7.5% of book
- Spencer Waxman - Shannon River Fund Management opened 5.7% of book
- Eric Khrom - Khrom Capital Management opened 5.2% of book
- Sachem Head Capital Management opened 4.1% of book
- Triple Frond Partners opened 3.8% of book
-
LPLA Lpl Financial Holdings, Inc. 5 managers avg 1.7% of book · King Street Capital Management, Senator Investment Group and 3 more
Opened by
- King Street Capital Management opened 5.1% of book
- Senator Investment Group opened 1.4% of book
- John Armitage - Egerton Capital (UK) opened 0.99% of book
- William Von Mueffling - Cantillon Capital Management opened 0.71% of book
- First Eagle Investment Management opened <0.01% of book
-
RKT Rocket Cos Inc. 4 managers avg 3.5% of book · Leon Cooperman - Omega Advisors, Philippe Laffont - Coatue Management and 2 more
Opened by
- Leon Cooperman - Omega Advisors opened 13.5% of book
- Philippe Laffont - Coatue Management opened 0.33% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.07% of book
- George Soros - Soros Fund Management opened <0.01% of book
-
AMD Advanced Micro Devices Inc. 4 managers avg 2.5% of book · Estuary Capital Management, Nehal Chopra - Ratan Capital Management and 2 more
Opened by
- Estuary Capital Management opened 6.5% of book
- Nehal Chopra - Ratan Capital Management opened 1.8% of book
- Glenview Capital Management opened 1.7% of book
- George Soros - Soros Fund Management opened 0.04% of book
-
FISV Fiserv, Inc. 4 managers avg 2.2% of book · Jana Partners Management, Samantha Mclemore - Patient Capital Management and 2 more
Opened by
- Jana Partners Management opened 7.8% of book
- Samantha Mclemore - Patient Capital Management opened 0.67% of book
- Christopher Davis - Davis Selected Advisers opened 0.17% of book
- Mason Hawkins - Southeastern Asset Management opened 0.01% of book
-
ISRG Intuitive Surgical Inc. 4 managers avg 1.6% of book · Mala Gaonkar - Surgocap Partners, Polen Capital Management and 2 more
Opened by
- Mala Gaonkar - Surgocap Partners opened 4.1% of book
- Polen Capital Management opened 2.0% of book
- Mairs & Power opened 0.34% of book
- Francois Rochon - Giverny Capital opened <0.01% of book
Closed out by the most managers
-
META Meta Platforms Inc. 10 managers was avg 3.0% of book · Stephen Mandel - Lone Pine Capital, Grant Wonders - Voyager Global Management and 8 more
Closed by
- Stephen Mandel - Lone Pine Capital closed was 7.1%
- Grant Wonders - Voyager Global Management closed was 5.4%
- Mala Gaonkar - Surgocap Partners closed was 4.3%
- John Armitage - Egerton Capital (UK) closed was 4.2%
- Ben Jacobs - Anomaly Capital Management closed was 3.2%
- Dan Loeb - Third Point closed was 1.8%
- Andreas Halvorsen - Viking Global Investors closed was 1.8%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.4%
and 2 more
-
BABA Alibaba Group Holding, Ltd. 7 managers was avg 1.6% of book · Glen Kacher - Light Street Capital Management, Guy Spier - Aquamarine Zurich AG and 5 more
Closed by
- Glen Kacher - Light Street Capital Management closed was 3.2%
- Guy Spier - Aquamarine Zurich AG closed was 2.7%
- Brad Gerstner - Altimeter Capital Management closed was 2.3%
- Ben Jacobs - Anomaly Capital Management closed was 1.7%
- Philippe Laffont - Coatue Management closed was 0.87%
- Lewis Sanders - Sanders Capital closed was 0.79%
- Polen Capital Management closed was <0.01%
-
SE Sea Ltd 7 managers was avg 1.3% of book · Alex Sacerdote - Whale Rock Capital Management, Stephen Mandel - Lone Pine Capital and 5 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 2.4%
- Stephen Mandel - Lone Pine Capital closed was 2.4%
- Glen Kacher - Light Street Capital Management closed was 2.1%
- Ryan Packard - Hiddenite Capital Partners closed was 1.3%
- Howard Marks - Oaktree Capital Management closed was 0.39%
- Sarah Ketterer - Causeway Capital Management closed was 0.36%
- Philippe Laffont - Coatue Management closed was 0.29%
-
FISV Fiserv, Inc. 7 managers was avg 1.3% of book · Francois Rochon - Giverny Capital, David Tepper - Appaloosa and 5 more
Closed by
- Francois Rochon - Giverny Capital closed was 2.6%
- David Tepper - Appaloosa closed was 1.6%
- Norbert Lou - Punch Card Management closed was 1.5%
- Robert Olstein - Olstein Capital Management closed was 1.4%
- David Katz - Matrix Asset Advisors closed was 0.94%
- Torray Investment Partners closed was 0.80%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
-
FLUT Flutter Entmt PLC 6 managers was avg 2.4% of book · John Armitage - Egerton Capital (UK), Stephen Mandel - Lone Pine Capital and 4 more
Closed by
- John Armitage - Egerton Capital (UK) closed was 3.8%
- Stephen Mandel - Lone Pine Capital closed was 3.2%
- Dan Loeb - Third Point closed was 3.2%
- Henry Ellenbogen - Durable Capital Partners closed was 2.3%
- Senator Investment Group closed was 1.5%
- Farallon Capital Management closed was 0.14%
-
INTU Intuit 6 managers was avg 1.2% of book · Henry Ellenbogen - Durable Capital Partners, Gavin Baker - Atreides Management and 4 more
Closed by
- Henry Ellenbogen - Durable Capital Partners closed was 2.2%
- Gavin Baker - Atreides Management closed was 1.8%
- Philippe Laffont - Coatue Management closed was 1.4%
- Farallon Capital Management closed was 1.4%
- Andreas Halvorsen - Viking Global Investors closed was 0.47%
- George Soros - Soros Fund Management closed was 0.08%
-
KMX Carmax Inc. 5 managers was avg 2.7% of book · Claude Leveille - Courant Investment Management, Francois Rochon - Giverny Capital and 3 more
Closed by
- Claude Leveille - Courant Investment Management closed was 8.8%
- Francois Rochon - Giverny Capital closed was 2.3%
- Wallace Weitz - Weitz Investment Management closed was 1.6%
- Steven Check - Check Capital Management closed was 0.89%
- Ruane, Cunniff & Goldfarb closed was <0.01%
-
VST Vistra Corp. 5 managers was avg 2.0% of book · Situational Awareness, Ryan Packard - Hiddenite Capital Partners and 3 more
Closed by
- Situational Awareness closed was 6.1%
- Ryan Packard - Hiddenite Capital Partners closed was 2.3%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.1%
- Philippe Laffont - Coatue Management closed was 0.25%
- Polen Capital Management closed was <0.01%
-
MDB Mongodb Inc. 5 managers was avg 1.5% of book · Glen Kacher - Light Street Capital Management, Ram Parameswaran - Octahedron Capital Management and 3 more
Closed by
- Glen Kacher - Light Street Capital Management closed was 3.6%
- Ram Parameswaran - Octahedron Capital Management closed was 2.8%
- Lee Ainslie - Maverick Capital closed was 0.57%
- Chase Coleman - Tiger Global Management closed was 0.33%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.14%
-
ZTS Zoetis Inc. 5 managers was avg 0.80% of book · Jensen Investment Management, Ako Capital and 3 more
Closed by
- Jensen Investment Management closed was 1.6%
- Ako Capital closed was 1.4%
- William Von Mueffling - Cantillon Capital Management closed was 0.97%
- Kentucky Trust Co. - Kentucky Trust closed was <0.01%
- Dodge & Cox closed was <0.01%
Where the money went
Net bought by sector, with price moves taken out. Pick a sector to see its names.
- Energy 4.1% weight · −0.1 pts +$4.9B 16 bought · 17 sold
- Real Estate 3.3% weight · no change +$4.2B 22 bought · 10 sold
- Industrials 10.2% weight · +0.4 pts +$1.7B 44 bought · 40 sold
- Materials 3.8% weight · +0.1 pts +$855M 24 bought · 20 sold
- Utilities 1.5% weight · −0.2 pts +$5M 12 bought · 8 sold
- Consumer Discretionary 15.6% weight · −0.1 pts −$1.6B 39 bought · 49 sold
- Consumer Staples 2.8% weight · −0.6 pts −$2.4B 9 bought · 25 sold
- Financials 17.1% weight · no change −$4.9B 34 bought · 55 sold
- Communication Services 9.2% weight · +0.3 pts −$5B 25 bought · 48 sold
- Health Care 12.8% weight · +0.2 pts −$5.2B 31 bought · 38 sold
- Information Technology 19.6% weight · −0.1 pts −$6.1B 42 bought · 54 sold
Communication Services gained weight (+0.3 pts) even though managers sold $5B of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): +$687M.
Who moved the most
The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.
Biggest new bets
- Leon Cooperman - Omega Advisors opened RKT · Rocket Cos Inc. 13.5% of book
- Sachem Head Capital Management opened SATS · Echostar Corp. 13.3% of book
- Alex Roepers - Atlantic Investment Management opened FLS · Flowserve Corp. 12.3% of book
- Valueact Capital - Valueact Holdings opened BLK · Blackrock Inc. 10.6% of book
- Dennis Hong - Shawspring Partners opened BABA · Alibaba Group Holding, Ltd. 10.4% of book
- Seth Klarman - Baupost Group opened AMZN · Amazon.com, Inc. 9.3% of book
Most active managers
- Estuary Capital Management 13 opened · 8 closed · −$33M net 141% of book traded
- Nehal Chopra - Ratan Capital Management 10 opened · 2 closed · +$185M net 109% of book traded
- Spencer Waxman - Shannon River Fund Management 10 opened · 5 closed · −$82M net 95% of book traded
- Sachem Head Capital Management 6 opened · 5 closed · +$465M net 86% of book traded
- Ram Parameswaran - Octahedron Capital Management 6 opened · 13 closed · −$30M net 81% of book traded
- Stanley Druckenmiller - Duquesne Family Office 20 opened · 26 closed · −$387M net 78% of book traded
What they hold
Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, each manager counting once. Highest conviction is the average position among holders, three or more.
Most owned
- 1 GOOGL / GOOG Alphabet 75 managers +5
- 2 MSFT Microsoft Corp. 64 managers +1
- 3 AMZN Amazon.com, Inc. 61 managers +8
- 4 META Meta Platforms Inc. 43 managers −9
- 5 TSM Taiwan Semiconductor Mfg Ltd 42 managers −1
- 6 NVDA Nvidia Corporation 40 managers +3
- 7 V Visa Inc. 36 managers +1
- 8 BRK.B / BRK.A Berkshire Hathaway 35 managers no change
- 9 DIS Disney Walt Co. 32 managers no change
- 10 UNH Unitedhealth Group, Inc. 31 managers −1
Largest
- 1 GOOGL / GOOG Alphabet 3.6% held by 75
- 2 AMZN Amazon.com, Inc. 2.6% held by 61
- 3 MSFT Microsoft Corp. 2.6% held by 64
- 4 BRK.B / BRK.A Berkshire Hathaway 2.5% held by 35
- 5 CVNA Carvana Co. Cl A 1.5% held by 15
- 6 NVDA Nvidia Corporation 1.3% held by 40
- 7 META Meta Platforms Inc. 1.3% held by 43
- 8 TSM Taiwan Semiconductor Mfg Ltd 1.2% held by 42
- 9 V Visa Inc. 0.99% held by 36
- 10 AAPL Apple Inc. 0.91% held by 30
Highest conviction
- 1 HHH Howard Hughes Holdings Inc. avg 20.1% held by 5
- 2 CVNA Carvana Co. Cl A avg 13.9% held by 15
- 3 JHG Janus Henderson Group PLC avg 13.1% held by 3
- 4 EQH Equitable Hldgs Inc. avg 11.3% held by 3
- 5 MDGL Madrigal Pharmaceuticals Inc. avg 10.2% held by 3
- 6 SNX Td Synnex Corporation avg 10.0% held by 5
- 7 BRK.B / BRK.A Berkshire Hathaway avg 9.5% held by 35
- 8 RIG Transocean Ltd avg 9.3% held by 3
- 9 TDG Transdigm Group Inc. avg 9.1% held by 8
- 10 IBKR Interactive Brokers Group In avg 8.4% held by 6
Did the combined book beat SPY?
Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.
Combined book, 8 quarters
+44.2%
SPY
+37.2%
Difference
+6.9 pts
2024 Q2, the start
+0.0% Combined book
+0.0% SPY
2024 Q3, since 2024 Q2
+7.5% Combined book
+5.4% SPY
That quarter: book +7.5%, SPY +5.4%
2024 Q4, since 2024 Q2
+10.2% Combined book
+7.7% SPY
That quarter: book +2.6%, SPY +2.1%
2025 Q1, since 2024 Q2
+6.0% Combined book
+2.8% SPY
That quarter: book −3.8%, SPY −4.6%
2025 Q2, since 2024 Q2
+18.3% Combined book
+13.5% SPY
That quarter: book +11.6%, SPY +10.5%
2025 Q3, since 2024 Q2
+29.0% Combined book
+22.4% SPY
That quarter: book +9.1%, SPY +7.8%
2025 Q4, since 2024 Q2
+31.8% Combined book
+25.3% SPY
That quarter: book +2.1%, SPY +2.4%
2026 Q1, since 2024 Q2
+25.9% Combined book
+19.5% SPY
That quarter: book −4.4%, SPY −4.6%
2026 Q2, since 2024 Q2
+44.2% Combined book
+37.2% SPY
That quarter: book +14.5%, SPY +14.8%
Quarter by quarter
| Quarter | Each manager once | By dollars | SPY | Book − SPY | Managers |
|---|---|---|---|---|---|
| 2026 Q2 | +14.5% | +11.5% | +14.8% | −0.4 pts | 133 |
| 2026 Q1 | −4.4% | −4.2% | −4.6% | +0.2 pts | 136 |
| 2025 Q4 | +2.1% | +2.6% | +2.4% | −0.2 pts | 136 |
| 2025 Q3 | +9.1% | +6.3% | +7.8% | +1.2 pts | 136 |
| 2025 Q2 | +11.6% | +8.0% | +10.5% | +1.1 pts | 136 |
| 2025 Q1 | −3.8% | −2.0% | −4.6% | +0.7 pts | 136 |
| 2024 Q4 | +2.6% | +1.1% | +2.1% | +0.4 pts | 134 |
| 2024 Q3 | +7.5% | +6.9% | +5.4% | +2.1 pts | 133 |
All 2,506 names
Download CSVShowing 300 of 394 matching names. The CSV has every name.
| Ticker | Company | Sector | Held by | Weight | Net bought | Bought / sold | Opened / closed |
|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group, Inc. | Health Care | 31 −1 | 0.29% | +$53M | 8 / 11 | 2 / 3 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 22 +1 | 0.23% | −$99M | 5 / 10 | 2 / 1 |
| DHR | Danaher Corporation | Health Care | 19 −1 | 0.26% | −$862M | 4 / 10 | 2 / 3 |
| JNJ | Johnson & Johnson | Health Care | 17 +1 | 0.12% | −$61M | 2 / 5 | 2 / 1 |
| CVS | Cvs Health Corp. | Health Care | 14 −1 | 0.36% | −$823M | 2 / 6 | 0 / 1 |
| ELV | Elevance Health Inc. Formerly | Health Care | 14 | 0.32% | +$320M | 2 / 4 | 0 / 0 |
| GEHC | Ge Healthcare Technologies, Inc. | Health Care | 13 +3 | 0.10% | +$920M | 7 / 0 | 3 / 0 |
| CI | The Cigna Group | Health Care | 12 | 0.12% | +$550M | 6 / 2 | 0 / 0 |
| MRK | Merck & Co. Inc. | Health Care | 12 | 0.10% | +$437M | 1 / 2 | 0 / 0 |
| PFE | Pfizer Inc. | Health Care | 12 | 0.10% | −$10M | 1 / 4 | 0 / 0 |
| ABBV | Abbvie Inc. | Health Care | 12 −1 | 0.04% | −$12M | 1 / 4 | 0 / 1 |
| BSX | Boston Scientific Corp. | Health Care | 11 +2 | 0.18% | +$311M | 3 / 4 | 2 / 0 |
| LLY | Eli Lilly & Co. | Health Care | 11 +1 | 0.11% | −$625M | 1 / 2 | 1 / 0 |
| MDT | Medtronic PLC | Health Care | 11 | 0.11% | −$270M | 0 / 4 | 0 / 0 |
| BMY | Bristol-Myers Squibb Co. | Health Care | 11 | 0.07% | +$165M | 5 / 5 | 2 / 2 |
| ABT | Abbott Labs | Health Care | 11 | 0.05% | −$507M | 0 / 2 | 0 / 0 |
| ICLR | Icon PLC | Health Care | 10 | 0.12% | +$53M | 3 / 4 | 2 / 2 |
| WST | West Pharmaceutical Svsc Inc. | Health Care | 10 | 0.11% | −$47M | 3 / 7 | 3 / 3 |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | 10 −1 | 0.08% | +$667M | 3 / 6 | 0 / 1 |
| NTRA | Natera Inc. | Health Care | 9 | 0.17% | +$185M | 1 / 7 | 0 / 0 |
| HCA | Hca Healthcare Inc. | Health Care | 9 | 0.15% | −$441M | 1 / 3 | 0 / 0 |
| BAX | Baxter Intl Inc. | Health Care | 9 | 0.09% | +$305M | 4 / 3 | 1 / 1 |
| IQV | Iqvia Hldgs Inc. | Health Care | 9 +1 | 0.07% | −$159M | 3 / 2 | 2 / 1 |
| MDLN | Medline Inc. IPO or spin-off | Health Care | 9 +9 | 0.07% | +$1.2B | 9 / 0 | 9 / 0 |
| TEVA | Teva Pharmaceutical Inds Ltd | Health Care | 8 −2 | 0.19% | −$769M | 1 / 8 | 0 / 2 |
| BDX | Becton Dickinson & Co. | Health Care | 8 | 0.12% | +$408M | 2 / 4 | 0 / 0 |
| GSK | Gsk PLC | Health Care | 8 | 0.07% | −$555M | 1 / 5 | 0 / 0 |
| ISRG | Intuitive Surgical Inc. | Health Care | 8 +4 | 0.06% | +$726M | 6 / 0 | 4 / 0 |
| AMGN | Amgen Inc. | Health Care | 8 | 0.05% | −$4M | 0 / 1 | 0 / 0 |
| NVS | Novartis AG | Health Care | 8 +1 | 0.02% | −$216M | 2 / 2 | 1 / 0 |
| THC | Tenet Healthcare Corp. | Health Care | 7 +1 | 0.16% | +$279M | 1 / 3 | 1 / 0 |
| IDXX | Idexx Labs Inc. | Health Care | 7 | 0.11% | −$683M | 0 / 4 | 0 / 0 |
| BIIB | Biogen Inc. | Health Care | 7 +1 | 0.11% | +$73M | 2 / 2 | 1 / 0 |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | 7 | 0.10% | +$89M | 2 / 1 | 0 / 0 |
| TECH | Bio-Techne Corp. | Health Care | 7 | 0.08% | +$26M | 3 / 1 | 0 / 0 |
| CAH | Cardinal Health Inc. | Health Care | 7 | 0.05% | +$66M | 1 / 2 | 0 / 0 |
| NVO | Novo-Nordisk A S | Health Care | 7 +1 | 0.02% | +$44M | 4 / 1 | 1 / 0 |
| DGX | Quest Diagnostics Inc. | Health Care | 7 | 0.02% | +$41M | 2 / 0 | 0 / 0 |
| ILMN | Illumina Inc. | Health Care | 6 −1 | 0.19% | −$6M | 1 / 1 | 0 / 1 |
| SOLV | Solventum Corporation | Health Care | 6 | 0.17% | +$41M | 2 / 1 | 0 / 0 |
| MCK | Mckesson Corp. | Health Care | 6 | 0.14% | −$58M | 1 / 4 | 0 / 0 |
| CNC | Centene Corp. Del | Health Care | 6 +1 | 0.06% | +$103M | 4 / 0 | 1 / 0 |
| VEEV | Veeva Sys Inc. | Health Care | 6 | 0.04% | −$106M | 0 / 3 | 0 / 0 |
| ALKS | Alkermes PLC | Health Care | 6 | 0.03% | −$192K | 2 / 1 | 0 / 0 |
| PTGX | Protagonist Therapeutics Inc. | Health Care | 6 +2 | 0.03% | +$5M | 2 / 0 | 2 / 0 |
| ROIV | Roivant Sciences Ltd | Health Care | 6 +2 | 0.01% | −$376M | 3 / 2 | 2 / 0 |
| INSM | Insmed Inc. | Health Care | 5 −1 | 0.14% | −$277M | 1 / 2 | 0 / 1 |
| ACHC | Acadia Healthcare Company In | Health Care | 5 −1 | 0.13% | −$25M | 3 / 3 | 1 / 2 |
| IONS | Ionis Pharmaceuticals Inc. | Health Care | 5 | 0.12% | −$50M | 1 / 2 | 0 / 0 |
| SYK | Stryker Corporation | Health Care | 5 −1 | 0.09% | −$494M | 0 / 5 | 0 / 1 |
| AVTR | Avantor, Inc. | Health Care | 5 | 0.07% | −$2M | 1 / 1 | 0 / 0 |
| ZTS | Zoetis Inc. | Health Care | 5 −4 | 0.06% | −$515M | 3 / 7 | 1 / 5 |
| SNY | Sanofi SA | Health Care | 5 | 0.06% | −$598M | 2 / 2 | 0 / 0 |
| MEDP | Medpace Holdings Inc. | Health Care | 5 | 0.04% | −$112M | 0 / 3 | 0 / 0 |
| NVST | Envista Holdings Corporation | Health Care | 5 | 0.04% | −$50M | 1 / 1 | 0 / 0 |
| HUM | Humana, Inc. | Health Care | 5 −1 | 0.04% | −$104M | 0 / 3 | 0 / 1 |
| HSIC | Henry Schein, Inc. | Health Care | 5 +1 | 0.03% | +$25M | 1 / 2 | 1 / 0 |
| BNTX | Biontech Se | Health Care | 5 | 0.03% | −$2M | 1 / 1 | 0 / 0 |
| BLCO | Bausch Plus Lomb Corp. | Health Care | 5 | 0.02% | +$20M | 2 / 1 | 0 / 0 |
| OSCR | Oscar Health Inc. | Health Care | 4 −2 | 0.19% | −$66M | 0 / 5 | 0 / 2 |
| BMRN | Biomarin Pharmaceutical, Inc. | Health Care | 4 | 0.14% | −$136M | 1 / 1 | 0 / 0 |
| RPRX | Royalty Pharma PLC | Health Care | 4 | 0.12% | +$6M | 2 / 1 | 0 / 0 |
| COO | Cooper Cos Inc. | Health Care | 4 | 0.12% | +$44M | 2 / 1 | 0 / 0 |
| WAT | Waters Corp. | Health Care | 4 +1 | 0.10% | −$170M | 1 / 3 | 1 / 0 |
| WGS | Genedx Holdings Corp. | Health Care | 4 | 0.09% | +$28M | 2 / 1 | 0 / 0 |
| VTRS | Viatris Inc. | Health Care | 4 | 0.07% | +$145M | 3 / 0 | 0 / 0 |
| TFX | Teleflex Incorporated | Health Care | 4 +1 | 0.07% | +$27M | 3 / 0 | 1 / 0 |
| BIO | Bio Rad Labs Inc. | Health Care | 4 | 0.06% | +$838K | 0 / 1 | 0 / 0 |
| MTD | Mettler Toledo International | Health Care | 4 +1 | 0.06% | −$31M | 1 / 1 | 1 / 0 |
| BBIO | Bridgebio Pharma Inc. | Health Care | 4 +1 | 0.05% | −$58M | 3 / 1 | 1 / 0 |
| ALGN | Align Technology Inc. | Health Care | 4 | 0.03% | +$184M | 3 / 2 | 1 / 1 |
| STOK | Stoke Therapeutics Inc. | Health Care | 4 +1 | 0.03% | −$2M | 1 / 2 | 1 / 0 |
| SNDX | Syndax Pharmaceuticals Inc. | Health Care | 4 +1 | 0.03% | +$305K | 2 / 1 | 1 / 0 |
| A | Agilent Technologies Inc. | Health Care | 4 | 0.03% | −$172M | 1 / 2 | 1 / 1 |
| CRL | Charles Riv Labs Intl Inc. | Health Care | 4 +1 | 0.03% | +$30M | 2 / 0 | 1 / 0 |
| NAMS | Newamsterdam Pharma Company | Health Care | 4 +1 | 0.03% | −$25M | 3 / 1 | 1 / 0 |
| EW | Edwards Lifesciences Corp. | Health Care | 4 −1 | 0.02% | −$262M | 1 / 1 | 0 / 1 |
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | 4 −2 | 0.02% | −$148M | 1 / 4 | 1 / 3 |
| LH | Labcorp Holdings Inc. | Health Care | 4 | 0.02% | −$9M | 1 / 2 | 0 / 0 |
| VRTX | Vertex Pharmaceuticals | Health Care | 4 −1 | 0.02% | −$33M | 0 / 2 | 0 / 1 |
| GILD | Gilead Sciences, Inc. | Health Care | 4 | 0.01% | −$474M | 1 / 2 | 0 / 0 |
| CDNA | Caredx Inc. | Health Care | 4 | 0.01% | +$4M | 2 / 0 | 0 / 0 |
| ADPT | Adaptive Biotechnologies Cor | Health Care | 4 +1 | 0.01% | −$16M | 2 / 1 | 1 / 0 |
| ASND | Ascendis Pharma A/S | Health Care | 4 −1 | 0.01% | −$4M | 0 / 3 | 0 / 1 |
| KPTI | Karyopharm Therapeutics Inc. | Health Care | 4 +3 | <0.01% | +$10M | 3 / 0 | 3 / 0 |
| NUVB | Nuvation Bio Inc. | Health Care | 4 +1 | <0.01% | −$4M | 1 / 1 | 1 / 0 |
| EHC | Encompass Health Corp. | Health Care | 4 −1 | <0.01% | −$55M | 0 / 3 | 0 / 1 |
| URGN | Urogen Pharma Ltd | Health Care | 4 | <0.01% | +$6M | 1 / 1 | 1 / 1 |
| RDNT | Radnet Inc. | Health Care | 4 | <0.01% | +$28M | 1 / 0 | 0 / 0 |
| HQY | Healthequity Inc. | Health Care | 4 +1 | <0.01% | −$634K | 1 / 1 | 1 / 0 |
| BTI | British Amern Tob PLC | Health Care | 4 | <0.01% | +$8M | 2 / 1 | 0 / 0 |
| INSP | Inspire Med Sys Inc. | Health Care | 4 +1 | <0.01% | +$13M | 2 / 2 | 1 / 0 |
| PGNY | Progyny Inc. | Health Care | 4 +1 | <0.01% | +$9M | 2 / 0 | 1 / 0 |
| MDGL | Madrigal Pharmaceuticals Inc. | Health Care | 3 | 0.22% | −$117M | 0 / 1 | 0 / 0 |
| SGRY | Surgery Partners Inc. | Health Care | 3 | 0.17% | +$57M | 3 / 1 | 1 / 1 |
| CGON | Cg Oncology Inc. | Health Care | 3 | 0.15% | −$5M | 0 / 1 | 0 / 0 |
| RVMD | Revolution Medicines Inc. | Health Care | 3 | 0.13% | −$8M | 0 / 1 | 0 / 0 |
| ENTA | Enanta Pharmaceuticals Inc. | Health Care | 3 +1 | 0.12% | +$22M | 3 / 0 | 1 / 0 |
| BHC | Bausch Health Cos Inc. | Health Care | 3 | 0.12% | +$19M | 2 / 0 | 0 / 0 |
| LQDA | Liquidia Corporation | Health Care | 3 +1 | 0.09% | −$2M | 1 / 1 | 1 / 0 |
| FOLD | Amicus Therapeutics Inc. | Health Care | 3 +1 | 0.08% | +$69M | 1 / 1 | 1 / 0 |
| ALC | Alcon AG | Health Care | 3 | 0.08% | −$14M | 1 / 1 | 0 / 0 |
| EXEL | Exelixis Inc. | Health Care | 3 | 0.08% | −$167M | 0 / 3 | 0 / 0 |
| INDV | Indivior Pharmaceuticals Inc. | Health Care | 3 | 0.06% | −$7M | 0 / 2 | 0 / 0 |
| UHS | Universal Hlth Svcs Inc. | Health Care | 3 −2 | 0.06% | −$111M | 1 / 4 | 0 / 2 |
| ORKA | Oruka Therapeutics Inc. | Health Care | 3 | 0.05% | $0 | 0 / 0 | 0 / 0 |
| ADMA | Adma Biologics Inc. | Health Care | 3 +2 | 0.04% | +$87M | 3 / 0 | 2 / 0 |
| CRSP | Crispr Therapeutics AG | Health Care | 3 | 0.03% | +$39M | 1 / 0 | 0 / 0 |
| INCY | Incyte Corp. | Health Care | 3 | 0.03% | −$59M | 1 / 1 | 0 / 0 |
| ANNX | Annexon Inc. | Health Care | 3 +2 | 0.03% | +$13M | 2 / 0 | 2 / 0 |
| AXGN | Axogen Inc. | Health Care | 3 | 0.03% | −$9M | 0 / 2 | 0 / 0 |
| BEAM | Beam Therapeutics Inc. | Health Care | 3 −2 | 0.03% | +$36M | 1 / 2 | 0 / 2 |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | 3 | 0.03% | +$2M | 1 / 1 | 1 / 1 |
| CATX | Perspective Therapeutics Inc. | Health Care | 3 +2 | 0.02% | +$6M | 3 / 0 | 2 / 0 |
| NBIX | Neurocrine Biosciences, Inc. | Health Care | 3 | 0.02% | −$7M | 0 / 0 | 0 / 0 |
| PGEN | Precigen Inc. | Health Care | 3 +2 | 0.02% | −$32M | 2 / 1 | 2 / 0 |
| RARE | Ultragenyx Pharmaceutical In | Health Care | 3 +1 | 0.02% | +$6M | 3 / 1 | 2 / 1 |
| DNLI | Denali Therapeutics Inc. | Health Care | 3 +1 | 0.02% | +$7M | 3 / 0 | 1 / 0 |
| MIRM | Mirum Pharmaceuticals Inc. | Health Care | 3 | 0.01% | +$7M | 1 / 0 | 0 / 0 |
| BKD | Brookdale Sr Living Inc. | Health Care | 3 +1 | 0.01% | +$37M | 2 / 0 | 1 / 0 |
| CMPS | Compass Pathways PLC | Health Care | 3 +1 | 0.01% | +$1M | 1 / 0 | 1 / 0 |
| DXCM | Dexcom Inc. | Health Care | 3 +1 | 0.01% | +$517K | 2 / 1 | 1 / 0 |
| BFLY | Butterfly Network Inc. | Health Care | 3 +1 | <0.01% | +$19M | 2 / 0 | 1 / 0 |
| VCYT | Veracyte Inc. | Health Care | 3 | <0.01% | −$24M | 0 / 1 | 0 / 0 |
| ELAN | Elanco Animal Health, Inc. | Health Care | 3 +1 | <0.01% | −$80M | 2 / 0 | 1 / 0 |
| XRAY | Dentsply Sirona Inc. | Health Care | 3 +1 | <0.01% | +$67M | 2 / 0 | 1 / 0 |
| GRAL | Grail Inc. | Health Care | 3 | <0.01% | +$85M | 1 / 1 | 0 / 0 |
| COR | Cencora Inc. | Health Care | 3 −1 | <0.01% | −$604M | 0 / 2 | 0 / 1 |
| HOLX | Hologic Inc. | Health Care | 3 | <0.01% | −$45M | 2 / 3 | 2 / 2 |
| SPRY | Ars Pharmaceuticals Inc. | Health Care | 3 +1 | <0.01% | +$7M | 2 / 0 | 1 / 0 |
| SDGR | Schrodinger Inc. | Health Care | 3 | <0.01% | +$468K | 1 / 1 | 0 / 0 |
| SRTA | Strata Critical Medical Inc. | Health Care | 3 | <0.01% | +$5M | 2 / 0 | 0 / 0 |
| VKTX | Viking Therapeutics Inc. | Health Care | 3 +1 | <0.01% | +$3M | 1 / 1 | 1 / 0 |
| GH | Guardant Health Inc. | Health Care | 3 | <0.01% | −$20K | 2 / 1 | 0 / 0 |
| EMBC | Embecta Corp. | Health Care | 3 | <0.01% | +$869K | 1 / 0 | 0 / 0 |
| BCYC | Bicycle Therapeutics Plc-Adr | Health Care | 3 | <0.01% | −$4K | 0 / 0 | 0 / 0 |
| Masimo | Masimo Corp. | Health Care | 3 | <0.01% | −$155M | 1 / 2 | 1 / 1 |
| CELC | Celcuity Inc. | Health Care | 3 +2 | <0.01% | +$624K | 2 / 1 | 2 / 0 |
| ESTA | Establishment Labs Hldgs Inc. | Health Care | 3 +1 | <0.01% | −$40M | 2 / 2 | 2 / 1 |
| UTHR | United Therapeutics Corp. | Health Care | 2 | 0.14% | −$3M | 0 / 1 | 0 / 0 |
| NVAX | Novavax Inc. | Health Care | 2 −1 | 0.14% | −$11M | 1 / 2 | 0 / 1 |
| JAZZ | Jazz Pharmaceuticals PLC | Health Care | 2 | 0.10% | −$44M | 0 / 1 | 0 / 0 |
| ACAD | Acadia Pharmaceuticals Inc. | Health Care | 2 | 0.07% | −$528K | 0 / 1 | 0 / 0 |
| SUPN | Supernus Pharmaceuticals Inc. | Health Care | 2 | 0.05% | −$2M | 0 / 1 | 0 / 0 |
| JBIO | Jade Biosciences Inc. | Health Care | 2 +1 | 0.05% | +$11M | 2 / 0 | 1 / 0 |
| IRON | Disc Medicine Inc. | Health Care | 2 | 0.04% | +$8M | 1 / 0 | 0 / 0 |
| ATRC | Atricure Inc. | Health Care | 2 +1 | 0.04% | +$5M | 1 / 0 | 1 / 0 |
| CYTK | Cytokinetics Inc. | Health Care | 2 | 0.04% | −$2M | 1 / 2 | 1 / 1 |
| ENOV | Enovis Corporation | Health Care | 2 | 0.04% | −$3M | 0 / 2 | 0 / 0 |
| SHC | Sotera Health Co. | Health Care | 2 | 0.04% | +$71M | 2 / 0 | 0 / 0 |
| DYN | Dyne Therapeutics Inc. | Health Care | 2 | 0.03% | +$4M | 1 / 0 | 0 / 0 |
| OPCH | Option Care Health Inc. | Health Care | 2 | 0.03% | +$74M | 2 / 0 | 0 / 0 |
| VNDA | Vanda Pharmaceuticals Inc. | Health Care | 2 | 0.03% | −$10K | 0 / 0 | 0 / 0 |
| PBH | Prestige Consmr Healthcare I | Health Care | 2 | 0.02% | +$31M | 1 / 0 | 0 / 0 |
| IOVA | Iovance Biotherapeutics Inc. | Health Care | 2 | 0.02% | −$1M | 0 / 1 | 0 / 0 |
| RGEN | Repligen Corp. | Health Care | 2 | 0.02% | +$31M | 2 / 0 | 0 / 0 |
| MOH | Molina Healthcare Inc. | Health Care | 2 +1 | 0.02% | +$50M | 1 / 1 | 1 / 0 |
| EWTX | Edgewise Therapeutics Inc. | Health Care | 2 | 0.02% | −$1M | 0 / 1 | 0 / 0 |
| OCUL | Ocular Therapeutix Inc. | Health Care | 2 +1 | 0.02% | +$219K | 1 / 0 | 1 / 0 |
| MBX | Mbx Biosciences Inc. | Health Care | 2 | 0.02% | +$3M | 1 / 0 | 0 / 0 |
| RMD | Resmed Inc. | Health Care | 2 | 0.01% | −$7K | 0 / 0 | 0 / 0 |
| WVE | Wave Life Sciences Ltd | Health Care | 2 | 0.01% | +$13M | 2 / 1 | 1 / 1 |
| COGT | Cogent Biosciences Inc. | Health Care | 2 | 0.01% | +$41M | 1 / 0 | 0 / 0 |
| BCAX | Bicara Therapeutics Inc. | Health Care | 2 +1 | 0.01% | +$4M | 1 / 1 | 1 / 0 |
| TWST | Twist Bioscience Corp. | Health Care | 2 | 0.01% | +$26M | 1 / 0 | 0 / 0 |
| LKFT | Galapagos NV | Health Care | 2 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| AGIO | Agios Pharmaceuticals Inc. | Health Care | 2 | 0.01% | −$18M | 0 / 2 | 0 / 0 |
| FMS | Fresenius Medical Care AG | Health Care | 2 | <0.01% | −$2M | 0 / 0 | 0 / 0 |
| CNTA | Centessa Pharmaceuticals PLC | Health Care | 2 +1 | <0.01% | +$67M | 2 / 0 | 1 / 0 |
| CAPR | Capricor Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$7M | 1 / 0 | 1 / 0 |
| TSHA | Taysha Gene Therapies Inc. | Health Care | 2 +1 | <0.01% | +$516K | 1 / 1 | 1 / 0 |
| IMVT | Immunovant Inc. | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| PHG | Koninklijke Philips NV | Health Care | 2 | <0.01% | +$7M | 2 / 0 | 0 / 0 |
| PRQR | Proqr Therapeutics N V | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BCRX | Biocryst Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| GPCR | Structure Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$30M | 1 / 1 | 1 / 0 |
| CAI | Caris Life Sciences Inc. | Health Care | 2 −1 | <0.01% | −$6M | 1 / 1 | 0 / 1 |
| TRVI | Trevi Therapeutics Inc. | Health Care | 2 | <0.01% | −$25M | 0 / 2 | 0 / 0 |
| PCVX | Vaxcyte Inc. | Health Care | 2 +1 | <0.01% | +$3M | 2 / 0 | 1 / 0 |
| HIMS | Hims & Hers Health Inc. | Health Care | 2 −1 | <0.01% | −$238M | 1 / 2 | 0 / 1 |
| BBNX | Beta Bionics Inc. | Health Care | 2 | <0.01% | +$625K | 1 / 0 | 0 / 0 |
| TVTX | Travere Therapeutics Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| KURA | Kura Oncology Inc. | Health Care | 2 +1 | <0.01% | −$1M | 1 / 1 | 1 / 0 |
| RCKT | Rocket Pharmaceuticals Inc. | Health Care | 2 +1 | <0.01% | −$18M | 1 / 1 | 1 / 0 |
| PROF | Profound Med Corp. | Health Care | 2 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| DOCS | Doximity Inc. | Health Care | 2 −2 | <0.01% | +$9M | 1 / 3 | 0 / 2 |
| MLYS | Mineralys Therapeutics Inc. | Health Care | 2 | <0.01% | −$32M | 0 / 2 | 0 / 0 |
| MMSI | Merit Med Sys Inc. | Health Care | 2 | <0.01% | −$99M | 0 / 1 | 0 / 0 |
| PODD | Insulet Corp. | Health Care | 2 | <0.01% | +$621K | 1 / 0 | 0 / 0 |
| ALLO | Allogene Therapeutics Inc. | Health Care | 2 | <0.01% | −$1K | 0 / 0 | 0 / 0 |
| KRYS | Krystal Biotech | Health Care | 2 | <0.01% | +$21K | 0 / 0 | 0 / 0 |
| PSNL | Personalis Inc. | Health Care | 2 +1 | <0.01% | +$156K | 1 / 0 | 1 / 0 |
| ORIC | Oric Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$297K | 1 / 0 | 0 / 0 |
| AXSM | Axsome Therapeutics | Health Care | 2 | <0.01% | −$479K | 0 / 1 | 0 / 0 |
| HALO | Halozyme Therapeutics | Health Care | 2 | <0.01% | +$12K | 0 / 0 | 0 / 0 |
| SION | Sionna Therapeutics Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| VSTM | Verastem Inc. IPO or spin-off | Health Care | 2 +2 | <0.01% | +$17M | 2 / 0 | 2 / 0 |
| TMDX | Transmedics Group Inc. Com | Health Care | 2 | <0.01% | +$625K | 1 / 0 | 0 / 0 |
| ABVX | Abivax SA | Health Care | 2 | <0.01% | −$55M | 1 / 1 | 0 / 0 |
| QURE | Uniqure NV | Health Care | 2 +1 | <0.01% | +$3M | 1 / 1 | 1 / 0 |
| PRME | Prime Medicine Inc. | Health Care | 2 | <0.01% | −$13M | 0 / 1 | 0 / 0 |
| Compugen | Compugen Ltd | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DNA | Ginkgo Bioworks Holdings Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BWAY | Brainsway Ltd | Health Care | 2 +1 | <0.01% | +$2M | 1 / 1 | 1 / 0 |
| BLLN | Billiontoone Inc. IPO or spin-off | Health Care | 2 +2 | <0.01% | +$15M | 2 / 0 | 2 / 0 |
| MRVI | Maravai Lifesciences Hldgs I | Health Care | 2 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| ARQT | Arcutis Biotherapeutics Inc. | Health Care | 2 | <0.01% | +$8M | 1 / 1 | 1 / 1 |
| ATEC | Alphatec Hldgs Inc. | Health Care | 2 | <0.01% | +$464K | 1 / 0 | 0 / 0 |
| ALVO | Alvotech SA | Health Care | 2 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| GRFS | Grifols S A | Health Care | 2 | <0.01% | −$411K | 0 / 0 | 0 / 0 |
| AORT | Artivion Inc. | Health Care | 2 +1 | <0.01% | −$376K | 1 / 1 | 1 / 0 |
| Inmode | Inmode Ltd | Health Care | 2 +1 | <0.01% | +$1M | 1 / 0 | 1 / 0 |
| SRRK | Scholar Rock Hldg Corp. | Health Care | 2 | <0.01% | +$163K | 1 / 0 | 0 / 0 |
| NUVL | Nuvalent Inc. | Health Care | 2 +1 | <0.01% | +$640K | 1 / 0 | 1 / 0 |
| HROW | Harrow Health Inc. | Health Care | 1 | 0.19% | $0 | 0 / 0 | 0 / 0 |
| DNTH | Dianthus Therapeutics Inc. | Health Care | 1 | 0.18% | −$45M | 0 / 1 | 0 / 0 |
| STXS | Stereotaxis Inc. | Health Care | 1 | 0.05% | $0 | 0 / 0 | 0 / 0 |
| ETON | Eton Pharmaceuticals Inc. | Health Care | 1 | 0.05% | $0 | 0 / 0 | 0 / 0 |
| LFCR | Lifecore Biomedical Inc. | Health Care | 1 | 0.04% | −$100K | 0 / 0 | 0 / 0 |
| RYTM | Rhythm Pharmaceuticals Inc. | Health Care | 1 | 0.03% | −$14M | 0 / 1 | 0 / 0 |
| ANAB | Anaptysbio Inc. | Health Care | 1 | 0.03% | +$801K | 0 / 0 | 0 / 0 |
| OGN | Organon & Co. | Health Care | 1 | 0.03% | +$90K | 0 / 0 | 0 / 0 |
| IDYA | Ideaya Biosciences Inc. | Health Care | 1 | 0.03% | −$1M | 0 / 1 | 0 / 0 |
| APGE | Apogee Therapeutics Inc. | Health Care | 1 | 0.03% | +$2M | 1 / 0 | 0 / 0 |
| SNWV | Sanuwave Health Inc. | Health Care | 1 | 0.03% | +$38K | 0 / 0 | 0 / 0 |
| Bausch Lomb | Bausch Lomb Corp. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| PRVA | Privia Health Group Inc. | Health Care | 1 | 0.02% | +$9M | 0 / 0 | 0 / 0 |
| SLGL | Sol Gel Technologies | Health Care | 1 | 0.02% | +$10M | 1 / 0 | 0 / 0 |
| BHVN | Biohaven Ltd | Health Care | 1 | 0.02% | +$8M | 1 / 0 | 0 / 0 |
| RCUS | Arcus Biosciences Inc. | Health Care | 1 | 0.02% | −$5M | 0 / 1 | 0 / 0 |
| FTRE | Fortrea Hldgs Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| NVCR | Novocure Ltd | Health Care | 1 | 0.02% | +$553K | 0 / 0 | 0 / 0 |
| CNTX | Context Therapeutics Inc. | Health Care | 1 | 0.02% | −$5M | 0 / 1 | 0 / 0 |
| TGTX | Tg Therapeutics Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| RZLT | Rezolute Inc. | Health Care | 1 | 0.01% | +$13M | 1 / 0 | 0 / 0 |
| CMPX | Compass Therapeutics Inc. | Health Care | 1 | 0.01% | +$9M | 1 / 1 | 1 / 1 |
| CBIO | Crescent Biopharma Inc. IPO or spin-off | Health Care | 1 +1 | 0.01% | +$14M | 1 / 0 | 1 / 0 |
| TNDM | Tandem Diabetes Care Inc. | Health Care | 1 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| PRTA | Prothena Corp. PLC | Health Care | 1 | 0.01% | −$34K | 0 / 0 | 0 / 0 |
| COLL | Collegium Pharmaceutical Inc. | Health Care | 1 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| LNTH | Lantheus Hldgs Inc. | Health Care | 1 | 0.01% | +$130M | 1 / 0 | 0 / 0 |
| CRNX | Crinetics Pharmaceuticals In | Health Care | 1 | 0.01% | +$54M | 1 / 0 | 0 / 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| DVA | Davita Inc. | Health Care | 1 | <0.01% | −$46M | 0 / 0 | 0 / 0 |
| INGN | Inogen Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| XOMA | Xoma Corp. Del | Health Care | 1 | <0.01% | +$997K | 1 / 0 | 0 / 0 |
| RXRX | Recursion Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$15M | 1 / 0 | 0 / 0 |
| Enhabit | Enhabit Inc. | Health Care | 1 | <0.01% | −$431K | 0 / 0 | 0 / 0 |
| DERM | Journey Medical Corp. | Health Care | 1 | <0.01% | +$30K | 0 / 0 | 0 / 0 |
| PHAT | Phathom Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| LZAGY | Lonza Group Adr | Health Care | 1 | <0.01% | −$280K | 0 / 0 | 0 / 0 |
| PRCT | Procept Biorobotics Corp. | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| LRMR | Larimar Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$15M | 0 / 2 | 0 / 1 |
| GMAB | Genmab A/S | Health Care | 1 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| LXEO | Lexeo Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$10M | 0 / 1 | 0 / 1 |
| NKTR | Nektar Therapeutics | Health Care | 1 −1 | <0.01% | −$33M | 1 / 1 | 0 / 1 |
| ALMS | Alumis Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| ITGR | Integer Hldgs Corp. | Health Care | 1 −1 | <0.01% | −$138M | 1 / 2 | 1 / 2 |
| ACRS | Aclaris Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| IPSC | Century Therapeutics Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| ELVN | Enliven Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$15M | 0 / 1 | 0 / 1 |
| VYGR | Voyager Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| RLMD | Relmada Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| TECX | Tectonic Therapeutics Inc. | Health Care | 1 | <0.01% | −$9M | 1 / 1 | 1 / 1 |
| PLX | Protalix Biotherapeutics Inc. | Health Care | 1 | <0.01% | −$184K | 0 / 0 | 0 / 0 |
| MPLT | Maplight Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| PVLA | Palvella Therapeutics Inc. Ne IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| MYGN | Myriad Genetics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| AQST | Aquestive Therapeutics Inc. | Health Care | 1 | <0.01% | −$883K | 0 / 1 | 0 / 0 |
| TNGX | Tango Therapeutics Inc. | Health Care | 1 | <0.01% | +$20M | 1 / 0 | 0 / 0 |
| DMAC | Diamedica Therapeutics Inc. | Health Care | 1 | <0.01% | −$10M | 0 / 1 | 0 / 0 |
| RAPP | Rapport Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| FBIO | Fortress Biotech Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| IVVD | Invivyd Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CLDX | Celldex Therapeutics Inc. New | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| COYA | Coya Therapeutics Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| MGTX | Meiragtx Holdings PLC | Health Care | 1 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| RIGL | Rigel Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| TELA | Tela Bio Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARGX | Argenx Se | Health Care | 1 | <0.01% | −$12M | 0 / 1 | 0 / 0 |
| VRCA | Verrica Pharmaceuticals Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$1M | 1 / 0 | 1 / 0 |
| ALEC | Alector Inc. | Health Care | 1 | <0.01% | +$172K | 1 / 0 | 0 / 0 |
| IART | Integra Lifesciences Hldgs | Health Care | 1 | <0.01% | −$199K | 0 / 1 | 0 / 0 |
| INBX | Inhibrx Biosciences Inc. | Health Care | 1 | <0.01% | −$28M | 0 / 1 | 0 / 0 |
| IRD | Opus Genetics Inc. | Health Care | 1 | <0.01% | +$40K | 0 / 0 | 0 / 0 |
| STRO | Sutro Biopharma Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| ABSI | Absci Corp. | Health Care | 1 | <0.01% | +$1M | 0 / 0 | 0 / 0 |
| SNN | Smith & Nephew PLC | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| PHVS | Pharvaris N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARAY | Accuray Inc. | Health Care | 1 | <0.01% | +$143K | 1 / 0 | 0 / 0 |
| CABA | Cabaletta Bio Inc. | Health Care | 1 | <0.01% | +$200K | 1 / 0 | 0 / 0 |
| TYRA | Tyra Biosciences Inc. | Health Care | 1 | <0.01% | +$24M | 1 / 0 | 0 / 0 |
| ZNTL | Zentalis Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| CERS | Cerus Corp. | Health Care | 1 | <0.01% | −$1M | 0 / 0 | 0 / 0 |
| EOLS | Evolus Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CORT | Corcept Therapeutics Inc. | Health Care | 1 | <0.01% | −$221K | 1 / 1 | 1 / 1 |
| ERAS | Erasca Inc. | Health Care | 1 | <0.01% | −$355K | 0 / 1 | 0 / 0 |
| NRIX | Nurix Therapeutics Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| ASMB | Assembly Biosciences Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
How the numbers work
Same managers in both quarters
Changes compare only managers with a 13F in both 2025 Q3 and 2025 Q4: 136 this time. New in 2025 Q4: Ning Jin - Avantyr Capital Partners.
Buying versus price
Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.
Who counts as a buyer or a seller
A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.
IPOs, spin-offs and mergers
A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.
Each manager once, or by dollars
By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.
Sectors
GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.
The combined book against SPY
Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.
What a 13F leaves out
Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.